Clinical trial
Stop Retinal Ganglion Cell Dysfunction Study
NCT02390284 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Stop Retinal Ganglion Cell Dysfunction Study
- Lead sponsor
- University of Miami
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- September 30, 2015
- Completion date
- October 4, 2024
- Enrollment
- 28 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.